Faculty Bibliography

[Jacqueline Kennedy Onassis]' condition was diagnosed in February, and in recent weeks, a health-care worker familiar with her case said she had been receiving radiation therapy to her brain, after the cancer was found to have spread there. She was also receiving chemotherapy directly into the brain. The health worker, who asked not to be identified, spoke out of concern that a mistaken impression of the care Onassis had received at New York Hospital-Cornell Medical Center might have resulted from statements made earlier this week by Nancy Tuckerman, a spokeswoman for Onassis. Tuckerman was quoted as saying: 'She's fine. She goes in for routine visits, routine treatment.' Hours before Onassis died Thursday, Tuckerman acknowledged that she had understated the severity of the situation but did so in order to respect the privacy of Onassis and her family

The type of cancer of the lymph system that Mrs. [Jacqueline Kennedy Onassis] had, non-Hodgkins lymphoma, is often treatable for years, and she had been reported to be responding well to treatment. As recently as Sunday, Mrs. Onassis was seen walking in Central Park. But the health worker familiar with her her care said she was unable to walk very far and needed to be supported by her companion, Maurice Tempelsman. Her condition was diagnosed in the winter, and in recent weeks, the health care worker said, she had been receiving radiation therapy to her brain, after the cancer was found to have spread there. She was also receiving chemotherapy directly into the brain. The cancer elsewhere in the body had initially responded to standard chemotherapy, including steroids, the health care worker said, but more recently had been found to have spread through her body. The health worker spoke out of concern that a mistaken impression of the care Mrs. Onassis had received at New York Hospital-Cornell Medical Center might have resulted from statements made earlier this week by Nancy Tuckerman, a spokeswoman for Mrs. Onassis. Tuckerman was quoted as saying: 'She's fine. She goes in for routine visits, routine treatment. That's what this is.'

The type of cancer of the lymph system that [Jacqueline Kennedy Onassis] had, non-Hodgkin's lymphoma, is often treatable for years, and she had been reported to be responding well to treatment. As recently as Sunday, Onassis was seen walking in Central Park. But she was unable to walk very far and needed to be supported by her companion, Maurice Tempelsman. Onassis's condition was diagnosed in the winter, and in recent weeks, the health care worker said, she had been receiving radiation therapy to her brain, after the cancer was found to have spread there. She also was receiving chemotherapy directly into the brain. Initially, the cancer elsewhere in the body had responded to standard chemotherapy, including steroids, the health care worker said. But more recently, it had been found to have spread through her body. The health worker, who asked not to be identified, spoke out of concern that a mistaken impression of the care Onassis had received at New York Hospital-Cornell Medical Center might have resulted from statements made earlier this week by Nancy Tuckerman, a spokeswoman for Onassis. Tuckerman was quoted as saying: 'She's fine. She goes in for routine visits, routine treatment. That's what this is.'

Bernard Fisher, who was forced to resign from the breast cancer study he coordinated for three decades, received standing ovations when he spoke before his peers at a Dallas meeting of the American Society of Clinical Oncology, of which he is immediate past president. However, on May 18, 1994, Fisher was accused by an editorial in the New England Journal of Medicine of failing to live up to his responsibilities as chief investigator of the study

Not so long ago, government officials and medical leaders all but pronounced the end of infectious diseases as a major public health problem. These striking examples of new and emerging diseases prove that prediction wrong. They join a list that includes, among others, AIDS, legionnaire's disease, Lyme disease, Lassa fever and bleeding and fever from the Ebola and Marburg viruses. Some were unknown or minor hazards only a decade or two ago. Others increased significantly in incidence over the last 20 years. Still others threaten to become bigger hazards in the near future. Infectious diseases are the leading cause of death in the world. The toll is swelling as a result of HIV, the virus that causes AIDS, which is estimated to have infected 14 million people, mainly in Africa and Asia, since it was first recognized in 1981. By 2000, experts estimate, the number infected will be 40 million. The sudden, unexpected appearance of AIDS shocked health officials into a belated recognition of the need for improved surveillance and an awareness that such vigilance might serve as an early warning system to prevent new and emerging infections from becoming public health disasters. But the report said, 'The ability to detect what is new or emerging depends on the capacity to identify and track the routine as well as the unusual.'

Infectious diseases are the leading cause of death in the world. The toll is swelling as a result of HIV, the virus that causes AIDS, which is estimated to have infected 14 million people, mainly in Africa and Asia, since it was first recognized in 1981. By 2000, experts estimate, the number infected will be 40 million. Not so long ago, government officials and medical leaders all but pronounced the end of infectious diseases as a major public health problem. These striking examples of new and emerging diseases prove that prediction wrong. They join a list that includes AIDS, Legionnaire's disease, Lyme disease, Lassa fever and bleeding and fever from the Ebola and Marburg viruses. Some were unknown or minor hazards only a decade or two ago. Others increased significantly in incidence over the past 20 years. Still others threaten to become bigger hazards in the near future

Federal health officials and researchers at the University of Pittsburgh came under renewed attack on May 11, 1994 at a congressional hearing for dealys in disclosing falsified data and other irregularities in major studies that changed the way breast cancer is treated

Medical researchers in New York City have found a strong correlation between low amounts of testosterone, the male sex hormone, and the degree of coronary artery disease, which underlies most heart attacks. The researchers, however, said they did not know precisely how low levels of testosterone might lead to a heart attack or normal amounts might protect against one

Not so long ago, Government officials and medical leaders all but pronounced the end of infectious diseases as a major public health problem. These striking examples of new and emerging diseases prove that prediction wrong. They join a list that includes, among others, AIDS, legionnaire's disease, Lyme disease, Lassa fever and bleeding and fever from the Ebola and Marburg viruses. Some were unknown or minor hazards only a decade or two ago. Others increased significantly in incidence over the last 20 years. Still others threaten to become bigger hazards in the near future. The sudden, unexpected appearance of AIDS shocked health officials into a belated recognition of the need for improved surveillance and an awareness that such vigilance might serve as an early warning system to prevent new and emerging infections from becoming public health disasters. But the report said, 'The ability to detect what is new or emerging depends on the capacity to identify and track the routine as well as the unusual.' Surveillance also relies on an effective laboratory system. Microbiologists can be the first to detect genetic changes in organisms that could signal an impending outbreak of antibiotic-resistant infections. Microbiologists can also be the first to detect known diseases that have spread to new geographic areas and populations. Laboratories can be vital for the early detection of exotic microbial agents that might be used for biological warfare or terrorist activities

Officials of the National Cancer Institute have threatened to cut off all financing for a breast cancer project coordinated at the University of Pittsburgh unless the university takes further steps to revamp the flawed project's leadership. Specifically, institute officials said they objected to retaining the project's two top scientists, Bernard Fisher and Carol Redmond, in leadership roles